Latest News

29

Mar 19

Canopy Biosciences Launches New Technology Vastly Improving Sensitivity of Next Generation Sequencing

ST. LOUIS, March 29, 2019 -- Canopy Biosciences™ LLC, a leading provider of gene editing and gene expression products and...
Read More

5

Mar 19

Canopy Biosciences Announces Exclusive License for Error Corrected Sequencing Technology

ST. LOUIS, March 5, 2019 /PRNewswire/ -- Canopy Biosciences™ LLC, a leading provider of gene editing and gene expression products...
Read More

9

Oct 18

Canopy Biosciences Announces Catalog of Genetically Engineered Cell Lines and Lysates

Canopy brings CRISPR technology within the reach of millions of researchers worldwide. Canopy BiosciencesTM, LLC, an established provider of gene...
Read More

22

May 18

BioGenerator and Kingdom Capital Lead $2.4 Million Series A Venture Capital Financing for Canopy Biosciences

Startup to Advance Research Tools Development and Add Jobs ST. LOUIS – Canopy Biosciences has exceeded its Series A financing...
Read More
0

Start typing and press Enter to search